OncoMark Ltd. is a private company centred on the development and application of biomarker panels, particularly supporting oncology drug development. A major focus of the company is to provide the link from -omic level discovery to validation via the use of multiplex antibody-based assays and high-throughput tissue microarray screening. OncoMark also conducts in-house research and development to (1) create unique multi-marker assays for use in the discrimination of patient response to drug therapies and (2) apply novel in-house image analysis toolkit for assessment of IHC-based markers at the subcellular compartmental level [IHC-MARK]. This is of particular benefit to the pharmaceutical and health authority sectors.
Looking for a particular Oncomark employee's phone or email?
The Oncomark annual revenue was $3 million in 2026.
3 people are employed at Oncomark.
Oncomark is based in Dublin, Leinster.
The NAICS codes for Oncomark are [54171, 54, 541713, 541, 5417].
The SIC codes for Oncomark are [87, 873].